GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit
PISCATAWAY, N.J., July 20, 2023 /PRNewswire/ -- GenScript USA Inc., the world's leading life-science research tools and services provider, announced its third annual GenScript Gene & Cell Engineering Virtual Summit, which will feature in-depth discussions and research presentations on the crucial gene-synthesis and cell-editing technologies that are transforming scientific and biomedical research today.
- This free Summit will be held on July 26, 2023, from 11 a.m. to 6 p.m. EDT.
- "As a leader in gene synthesis and gene editing technologies, GenScript has been fortunate to work with many pioneering scientists in cell and gene engineering," said Ray Chen, Ph.D., president of GenScript Life Science Group.
- The summit showcases the role of genetic engineering in revolutionizing life-science research, advancing gene and cell therapies, and enabling the efficient development of invaluable biotherapeutics for various human diseases.
- Dr. Yongli Shan, associate director of discovery biology at Vicinitas Therapeutics — Advancing protein stabilization therapeutic development and DUBTAC drug discovery through gene and cell engineering.